Theriva Biologics, Inc. Property, Plant and Equipment, Gross
Theriva Biologics, Inc. (TOVX) had Property, Plant and Equipment, Gross of $1.18 million as of 2026-06-30, per its 10-Q filed 2026-08-11.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent › Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization
us-gaap:PropertyPlantAndEquipmentGross · last filed 2026-08-11
- 2026-06-30: Property, Plant and Equipment, Gross $1.18M.
- 2026-03-31: Property, Plant and Equipment, Gross $1.18M.
- 2025-12-31: Property, Plant and Equipment, Gross $1.19M.
- 2025-09-30: Property, Plant and Equipment, Gross $1.24M.
| Period end | Property, Plant and Equipment, Gross |
|---|---|
| 2026-06-30 | $1.18M 10-Q · filed 2026-08-11 |
| 2026-03-31 | $1.18M 10-Q · filed 2026-05-05 |
| 2025-12-31 | $1.19M 10-Q · filed 2026-08-11 |
| 2025-09-30 | $1.24M 10-Q · filed 2025-11-12 |
| 2025-06-30 | $1.28M 10-Q · filed 2025-08-11 |
| 2025-03-31 | $1.23M 10-Q · filed 2025-05-14 |
| 2024-12-31 | $1.21M 10-K · filed 2026-03-12 |
| 2024-09-30 | $1.24M 10-Q · filed 2024-11-12 |
| 2024-06-30 | $1.22M 10-Q · filed 2024-08-13 |
| 2024-03-31 | $1.41M 10-Q · filed 2024-05-07 |
| 2023-12-31 | $1.42M 10-K · filed 2025-03-06 |
| 2023-09-30 | $1.35M 10-Q · filed 2023-11-13 |
| 2023-06-30 | $1.23M 10-Q · filed 2023-08-08 |
| 2023-03-31 | $1.22M 10-Q · filed 2023-05-11 |
| 2022-12-31 | $1.21M 10-K · filed 2024-03-25 |
| 2022-09-30 | $1.10M 10-Q · filed 2022-11-10 |
| 2022-06-30 | $1.10M 10-Q · filed 2022-08-11 |
| 2022-03-31 | $1.46M 10-Q · filed 2022-05-16 |
| 2021-12-31 | $932.00K 10-K · filed 2023-03-30 |
| 2021-09-30 | $932.00K 10-Q · filed 2021-11-03 |
| 2021-06-30 | $932.00K 10-Q · filed 2021-08-05 |
| 2021-03-31 | $1.28M 10-Q · filed 2021-05-05 |
| 2020-12-31 | $1.26M 10-K · filed 2022-03-16 |
| 2020-09-30 | $1.26M 10-Q · filed 2020-11-10 |
| 2020-06-30 | $1.25M 10-Q · filed 2020-08-06 |
| 2020-03-31 | $1.25M 10-Q · filed 2020-05-05 |
| 2019-12-31 | $1.25M 10-K · filed 2021-03-04 |
| 2019-09-30 | $1.30M 10-Q · filed 2019-11-04 |
| 2019-06-30 | $1.30M 10-Q · filed 2019-08-08 |
| 2019-03-31 | $1.30M 10-Q · filed 2019-05-08 |
| 2018-12-31 | $1.30M 10-K · filed 2020-02-20 |
| 2018-09-30 | $1.30M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $1.30M 10-Q · filed 2018-08-08 |
| 2018-03-31 | $1.30M 10-Q · filed 2018-05-08 |
| 2017-12-31 | $1.30M 10-K · filed 2019-02-27 |
| 2017-09-30 | $1.30M 10-Q · filed 2017-11-01 |
| 2017-06-30 | $1.10M 10-Q · filed 2017-08-03 |
| 2017-03-31 | $1.10M 10-Q · filed 2017-05-04 |
| 2016-12-31 | $1.09M 10-K · filed 2018-02-22 |
| 2016-09-30 | $773.00K 10-Q · filed 2016-11-01 |
| 2016-06-30 | $636.00K 10-Q · filed 2016-08-03 |
| 2016-03-31 | $624.00K 10-Q · filed 2016-05-05 |
| 2015-12-31 | $599.00K 10-K · filed 2017-03-02 |
| 2015-09-30 | $555.00K 10-Q · filed 2015-11-05 |
| 2015-06-30 | $165.00K 10-Q · filed 2015-08-10 |
| 2015-03-31 | $122.00K 10-Q · filed 2015-05-11 |
| 2014-12-31 | $104.00K 10-K · filed 2016-03-10 |
| 2014-09-30 | $99.00K 10-Q · filed 2014-11-14 |
| 2014-06-30 | $77.00K 10-Q · filed 2014-08-14 |
| 2014-03-31 | $60.00K 10-Q · filed 2014-05-15 |
| 2013-12-31 | $56.00K 10-K · filed 2015-03-16 |
| 2013-09-30 | $330.00K 10-Q · filed 2013-11-14 |
| 2013-06-30 | $333.00K 10-Q · filed 2013-08-14 |
| 2013-03-31 | $468.00K 10-Q · filed 2013-05-15 |
| 2012-12-31 | $465.00K 10-K · filed 2014-03-31 |
| 2012-09-30 | $500.00K 10-Q · filed 2012-11-14 |
| 2012-06-30 | $493.00K 10-Q/A · filed 2012-09-11 |
| 2011-12-31 | $695.00K 10-K · filed 2013-04-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| KALA BIO, Inc. (KALA) | United States | $0.011B | -3.33 |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| Azitra, Inc. (AZTR) | United States | $0.010B | -0.81 |
| Medicus Pharma Ltd. (MDCX) | $0.010B | ||
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aprea Therapeutics, Inc. (APRE) | United States | $0.010B | -0.78 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |